Sequential Intravesical Gemcitabine and Docetaxel is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non-muscle-invasive Bladder Cancer

Wei Shen Tan, Ian M. McElree, Facundo Davaro, Ryan L. Steinberg, Kelly Bree, Neema Navai, Colin P. Dinney, Michael A. O'Donnell, Roger Li, Ashish M. Kamat, Vignesh T. Packiam

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Sequential Intravesical Gemcitabine and Docetaxel is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non-muscle-invasive Bladder Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences